237 related articles for article (PubMed ID: 22205228)
41. The Vasopressin Receptor 2 Mutant R137L Linked to the Nephrogenic Syndrome of Inappropriate Antidiuresis (NSIAD) Signals through an Alternative Pathway that Increases AQP2 Membrane Targeting Independently of S256 Phosphorylation.
Ranieri M; Venneri M; Pellegrino T; Centrone M; Di Mise A; Cotecchia S; Tamma G; Valenti G
Cells; 2020 May; 9(6):. PubMed ID: 32486031
[TBL] [Abstract][Full Text] [Related]
42. Rab7 involves Vps35 to mediate AQP2 sorting and apical trafficking in collecting duct cells.
Wang WL; Su SH; Wong KY; Yang CW; Liu CF; Yu MJ
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F956-F970. PubMed ID: 32088968
[TBL] [Abstract][Full Text] [Related]
43. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct.
Marples D; Knepper MA; Christensen EI; Nielsen S
Am J Physiol; 1995 Sep; 269(3 Pt 1):C655-64. PubMed ID: 7573395
[TBL] [Abstract][Full Text] [Related]
44. Loss of primary cilia results in deregulated and unabated apical calcium entry in ARPKD collecting duct cells.
Siroky BJ; Ferguson WB; Fuson AL; Xie Y; Fintha A; Komlosi P; Yoder BK; Schwiebert EM; Guay-Woodford LM; Bell PD
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1320-8. PubMed ID: 16396941
[TBL] [Abstract][Full Text] [Related]
45. Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.
Arystarkhova E; Bouley R; Liu YB; Sweadner KJ
PLoS One; 2017; 12(11):e0188006. PubMed ID: 29155857
[TBL] [Abstract][Full Text] [Related]
46. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
Juul KV; Bichet DG; Nielsen S; Nørgaard JP
Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
[TBL] [Abstract][Full Text] [Related]
47. Expression Regulation and Trafficking of Aquaporins.
Zhao X; Liang B; Li C; Wang W
Adv Exp Med Biol; 2023; 1398():39-51. PubMed ID: 36717485
[TBL] [Abstract][Full Text] [Related]
48. Data resource: vasopressin-regulated protein phosphorylation sites in the collecting duct.
Park E; Yang CR; Raghuram V; Deshpande V; Datta A; Poll BG; Leo KT; Kikuchi H; Chen L; Chou CL; Knepper MA
Am J Physiol Renal Physiol; 2023 Jan; 324(1):F43-F55. PubMed ID: 36264882
[TBL] [Abstract][Full Text] [Related]
49. Vasopressin receptor-mediated functional signaling pathway in primary cilia of renal epithelial cells.
Raychowdhury MK; Ramos AJ; Zhang P; McLaughin M; Dai XQ; Chen XZ; Montalbetti N; Del Rocío Cantero M; Ausiello DA; Cantiello HF
Am J Physiol Renal Physiol; 2009 Jan; 296(1):F87-97. PubMed ID: 18945824
[TBL] [Abstract][Full Text] [Related]
50. The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment.
Tamma G; Di Mise A; Ranieri M; Geller A; Tamma R; Zallone A; Valenti G
J Cell Mol Med; 2017 Sep; 21(9):1767-1780. PubMed ID: 28326667
[TBL] [Abstract][Full Text] [Related]
51. Altered arginine vasopressin-cyclic AMP-aquaporin 2 pathway in patients with chronic kidney disease.
Kakeshita K; Koike T; Imamura T; Fujioka H; Yamazaki H; Kinugawa K
Clin Exp Nephrol; 2022 Aug; 26(8):788-796. PubMed ID: 35503490
[TBL] [Abstract][Full Text] [Related]
52. NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity.
Féraille E; Dizin E; Roth I; Derouette JP; Szanto I; Martin PY; de Seigneux S; Hasler U
PLoS One; 2014; 9(1):e87239. PubMed ID: 24466344
[TBL] [Abstract][Full Text] [Related]
53. Cyclophosphamide-induced vasopressin-independent activation of aquaporin-2 in the rat kidney.
Kim S; Choi HJ; Jo CH; Park JS; Kwon TH; Kim GH
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F474-83. PubMed ID: 26109089
[TBL] [Abstract][Full Text] [Related]
54. Vasopressin regulates apical targeting of aquaporin-2 but not of UT1 urea transporter in renal collecting duct.
Inoue T; Terris J; Ecelbarger CA; Chou CL; Nielsen S; Knepper MA
Am J Physiol; 1999 Apr; 276(4):F559-66. PubMed ID: 10198415
[TBL] [Abstract][Full Text] [Related]
55. Inner Ear Arginine Vasopressin-Vasopressin Receptor 2-Aquaporin 2 Signaling Pathway Is Involved in the Induction of Motion Sickness.
Xu LH; Yang Y; Liu HX; Xiao SF; Qiu WX; Wang JX; Zhao CC; Gui YH; Liu GZ; Peng B; Li X; Wang GH; Zhou X; Jiang ZL
J Pharmacol Exp Ther; 2020 May; 373(2):248-260. PubMed ID: 32165443
[TBL] [Abstract][Full Text] [Related]
56. Phosphoproteomic identification of vasopressin V2 receptor-dependent signaling in the renal collecting duct.
Deshpande V; Kao A; Raghuram V; Datta A; Chou CL; Knepper MA
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F789-F804. PubMed ID: 31313956
[TBL] [Abstract][Full Text] [Related]
57. Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells.
Moeller HB; Knepper MA; Fenton RA
Kidney Int; 2009 Feb; 75(3):295-303. PubMed ID: 18843259
[TBL] [Abstract][Full Text] [Related]
58. Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability.
Wang F; Xu C; Luo R; Peng K; Ramkumar N; Xie S; Lu X; Zhao L; Zuo CJ; Kohan DE; Yang T
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944256
[TBL] [Abstract][Full Text] [Related]
59. Atrial natriuretic peptide and nitric oxide signaling antagonizes vasopressin-mediated water permeability in inner medullary collecting duct cells.
Klokkers J; Langehanenberg P; Kemper B; Kosmeier S; von Bally G; Riethmüller C; Wunder F; Sindic A; Pavenstädt H; Schlatter E; Edemir B
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F693-703. PubMed ID: 19570884
[TBL] [Abstract][Full Text] [Related]
60. Polarized Trafficking of AQP2 Revealed in Three Dimensional Epithelial Culture.
Rice WL; Li W; Mamuya F; McKee M; Păunescu TG; Lu HA
PLoS One; 2015; 10(7):e0131719. PubMed ID: 26147297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
